EUIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Unionsmarke ABILEAP wurde als Wortmarke am 18.06.2024 beim Amt der Europäischen Union für Geistiges Eigentum angemeldet. Der aktuelle Status der Marke ist "Anmeldung eingereicht".
| Markenform | Wortmarke |
| Aktenzeichen | 019042452 |
| Anmeldedatum | 18. Juni 2024 |
Markenvertreter
Via Borgonuovo, 10
20121 Milano
IT
Waren und Dienstleistungen
1
antibody products and molecules for scientific and medical purposes
5
antibody products and molecules acting as immune modulators for scientific and medical purposes; colostral antibodies for medical purposes; pharmaceutical antibodies for the treatment of hereditary angioedema (HAE); pharmaceutical antibodies for the treatment of respiratory diseases and respiratory syndromes; pharmaceutical antibody preparations for auto-immune diseases; pharmaceutical antibody preparations for the prevention and treatment of auto-immune diseases; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories
42
antibody profiling for scientific research purposes, for discovery and development of new biotherapeutics; operation of scientific database and website regarding research in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; molecule development; clinical trials; providing temporary use of a non-downloadable software for managing information in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; Platform as a service [PaaS] for analyzing molecular and clinical data to develop antibodies against immune targets; analysis in the field of molecular biology; molecular analysis and product optimization for the purpose of pharmaceutical development
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 11019042452